A drug to suppress lactation after childbirth could reduce the risk of breast cancer, according to an international study.
World1 source1 country🔦 Under-reported3m ago
An international team of researchers, including experts from the Salamanca Cancer Research Center (CIC), has conducted a study investigating the effects of a medication used to suppress lactation and halt breast milk production after childbirth. According to the findings, administration of this drug could potentially reduce the risk of developing breast cancer.
The research involved testing in animal models, where scientists observed that the drug's application cut the risk of contracting breast cancer by half. The findings were reported from Madrid on October 15, highlighting a potential new preventive application for an existing postpartum medication.
In-depth summary · AI, neutral
How the coverage differs
Same story, different emphasis — here's what each outlet chose to lead with.
Infobae (Buenos Aires, Argentina) (AR) (Snippet 1)Highlights the involvement of Spanish researchers from the CIC.
Infobae (Buenos Aires, Argentina) (AR) (Snippet 2)Emphasizes animal model testing and a 50% risk reduction.
Newz